Dr. Jeffrey A. Olson, DO
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 688
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
IN license 02002664A -
Cardiovascular Disease Physician
IN license 02002664A -
Internal Medicine Physician
IN license 02002664A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ascension St Vincent Hospital Indianapolis, IN
- Ascension St Vincent Kokomo Kokomo, IN
- Memorial Hospital and Health Care Center Jasper, IN
- Schneck Medical Center Seymour, IN
- St Vincent Heart Center Carmel, IN
Medical groups
- St Vincent Medical Group Inc (736 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 688
- Services billed
- 3,304
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 727 | 231 |
| Established patient office or other outpatient visit, 30-39 minutes | 540 | 436 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 524 | 166 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 465 | 158 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 392 | 290 |
| Programming of dual lead pacemaker system | 156 | 108 |
| Programming of multiple lead implantable defibrillator system | 80 | 70 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 59 | 38 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 49 | 48 |
| Programming of heart rhythm stimulation after drug infusion | 43 | 42 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Indianapolis, IN | 479 |
| Metoprolol Succinate Other prescribers in Indianapolis, IN | 305 |
| Xarelto (rivaroxaban) Other prescribers in Indianapolis, IN | 110 |
| Amiodarone Hcl Other prescribers in Indianapolis, IN | 77 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Indianapolis, IN | 75 |
| Flecainide Acetate Other prescribers in Indianapolis, IN | 75 |
| Sotalol (sotalol hcl) Other prescribers in Indianapolis, IN | 62 |
| Warfarin Sodium Other prescribers in Indianapolis, IN | 59 |
| Diltiazem 24hr Er (Cd) (diltiazem hcl) Other prescribers in Indianapolis, IN | 52 |
| Metoprolol Tartrate Other prescribers in Indianapolis, IN | 51 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 33 payments worth $2,516 in total to this clinician.
| Boston Scientific Corporation | $1,168 |
|---|---|
| Medtronic, Inc. | $654 |
| Biotronik Inc. | $293 |
| Abbott Laboratories | $216 |
| Biosense Webster, Inc. | $136 |
| Cardiva Medical, Inc. | $48.83 |
| Food and Beverage | $2,516 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $8,905 in research payments for these studies, mostly to the institutions running them.
- NCT04226547--Amplatzer Amulet LAAO vs. NOAC
Abbott Laboratories - A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation
Boston Scientific Corporation · Completed · NCT05443594 - Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Boston Scientific Corporation · Completed · NCT03795298
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.